Follow the 에이비프로바이오 stock price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Industrials sector, 에이비프로바이오 has published 53 public disclosures. Market capitalisation: €19.3bn. The latest transaction was filed on 27 May 2026 (Other). Among the most active insiders: 상상인저축은행. All data is accessible without an account.
53
Insider Decl.
n/a
Thresholds
€2m
34 ops.
Buy Volume
n/a
2 ops.
Sell Volume
10Σ signal
Buys €2mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Establecida en el sector industrial, 에이비프로바이오 es una empresa que cotiza en el mercado XKRX. Se especializa en el desarrollo de productos biofarmacéuticos.